Amla on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
Amla has demonstrated promising effects in the treatment of obesity, dyslipidemia,
hypertension, insulin secretion, among others. The above mentioned findings show that Amla
has an excellent potential for the prevention and treatment of metabolic syndrome.